Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
44
group A will receive ketamine intravenous infusion
group B will receive lidocaine intravenous infusion
group C will only receive Dextrose 5% in water
Changes in pain scale using Numeric rating scale
Pain assessment by using a Numeric rating scale (0 (no pain) to 10 (worst possible pain). Scores of 1-3 are considered mild, 4-6 moderate, and 7-10 severe) before the infusion and daily for 1-week post infusion, then weekly for 6 weeks post infusion
Time frame: From enrollment to the end of treatment at 6 weeks
Changes in pain scale using Migraine disability assessment
Migraine disability assessment test before the infusion and daily for 1-week post infusion, then weekly for 6 weeks post infusion
Time frame: From enrollment to the end of treatment at 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.